Answers are grounded in this paper and cite their sources.
Background: Anti-inflammatory therapies for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) remain limited. Natural products are promising sources of bioactive compounds; Artocarpus heterophyllus (AH; jackfruit) peel waste and Sonchus arvensis L. (SA; tempuyung) leaves contain phytochemicals with anti-inflammatory potential. This study evaluated an inhalable nanoemulgel containing both extracts in bleomycin- induced ALI rats.Materials and methods: AH peel and SA leaves were separately macerated in 70% ethanol for 24 h and 96% ethanol for 72 h, respectively. The extracts were combined (25% each) in a sodium alginate nanoemulgel prepared using aqueous alginate and PEG 7-virgin coconut oil phases, CaCl2-mediated gelation, and centrifugation. Male Wistar rats (n = 24) were randomized to healthy controls or bleomycin-induced groups receiving no extract or nebulized nanoemulgel (400 or 800 mg/kg; n = 6/group). ALI was induced by intratracheal bleomycin (0.75 U/kg). Lung IL-6, alveolar septal thickening, and pulmonary hemorrhage were assessed by ELISA and hematoxylin-eosin staining.Results: Bleomycin increased lung IL-6, alveolar septal thickening, and pulmonary hemorrhage compared with healthy controls (all p<0.0001). Compared with untreated bleomycin-induced rats, 400 mg/kg nanoemulgel reduced IL-6 (p<0.001) and hemorrhage (p<0.0001), but not septal thickening. The 800 mg/kg dose reduced IL-6 and hemorrhage (both p<0.0001) and septal thickening (p<0.001).Conclusion: Nebulized AH-SA nanoemulgel reduced lung IL-6 and pulmonary hemorrhage at both doses, whereas alveolar septal thickening was reduced only at 800 mg/kg. These findings warrant further evaluation of this inhalable formulation for ALI.
No takes yet. Share an insight, caveat, or question.
Triadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: